[Effectiveness of and tolerance to azithromycin versus roxithromycin in the treatment of patients with acute infections of the upper respiratory tract].
A multicenter open prospective comparative study was carried out during two years enrolling 60 patients with upper respiratory infections. Thirty were treated with single daily 500 mg doses of azithromycin for three days, and 30 received two daily doses of roxithromycin of 150 mg each for seven days. Both treatments were equally well tolerated, and there was no substantial difference concerning clinical recovery. However, azithromycin treatment was more practical and of shorter duration.
Bosatra
A
A
Clinica ORL, Ospedale Cattinara, Trieste.
Tattoni
P
P
Podda
M
M
Pirodda
E
E
Buccolieri
M
M
Amorosa
L
L
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D017963:Azithromycin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D015575:Roxithromycin / Q000009:adverse effects / Q000627:therapeutic use*
D015575:Roxithromycin; D017963:Azithromycin
Studio sull'efficacia e la tollerabilità dell'azitromicina vs roxitromicina nel trattamento di pazienti con infezioni acute delle alte vie respiratorie.